[HTML][HTML] Nothing but NET: a review of neuroendocrine tumors and carcinomas

B Oronsky, PC Ma, D Morgensztern, CA Carter - Neoplasia, 2017 - Elsevier
This review covers the diverse topic of neuroendocrine neoplasms (NENs), a relatively rare
and heterogeneous tumor type, comprising~ 2% of all malignancies, with a prevalence of< …

Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame

V Marotta, MC Zatelli, C Sciammarella… - Endocrine-related …, 2018 - erc.bioscientifica.com
Owing to the heterogeneity of neuroendocrine neoplasms (NENs), the availability of reliable
circulating markers is critical for improving diagnostics, prognostic stratification, follow-up …

The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors

JR Howe, NB Merchant, C Conrad, XM Keutgen… - Pancreas, 2020 - journals.lww.com
This manuscript is the result of the North American Neuroendocrine Tumor Society
consensus conference on the surgical management of pancreatic neuroendocrine tumors …

Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: a SEER database analysis of 162,983 cases

A Dasari, K Mehta, LA Byers, H Sorbye, JC Yao - Cancer, 2018 - Wiley Online Library
BACKGROUND Extrapulmonary neuroendocrine carcinomas (NECs) are poorly studied and
are managed similar to lung NECs, which may not account for differences between the 2 …

Alternative lengthening of telomeres and loss of DAXX/ATRX expression predicts metastatic disease and poor survival in patients with pancreatic neuroendocrine …

AD Singhi, TC Liu, JL Roncaioli, D Cao, HJ Zeh… - Clinical Cancer …, 2017 - AACR
Abstract Purpose: Pancreatic neuroendocrine tumors (PanNET) are a heterogeneous group
of neoplasms with increasing incidence and unpredictable behavior. Whole-exome …

NANETS/SNMMI procedure standard for somatostatin receptor–based peptide receptor radionuclide therapy with 177Lu-DOTATATE

TA Hope, A Abbott, K Colucci, DL Bushnell… - Journal of Nuclear …, 2019 - Soc Nuclear Med
With the recent approval of 177Lu-DOTATATE for use in gastroenteropancreatic
neuroendocrine tumors, access to peptide receptor radionuclide therapy is increasing …

INSM1 is a sensitive and specific marker of neuroendocrine differentiation in head and neck tumors

LM Rooper, JA Bishop, WH Westra - The American journal of …, 2018 - journals.lww.com
The head and neck is the site of a wide and sometimes bewildering array of neuroendocrine
(NE) tumors. Although recognition of NE differentiation may be necessary for appropriate …

Recent updates on neuroendocrine tumors from the gastrointestinal and pancreatobiliary tracts

JY Kim, SM Hong - Archives of pathology & laboratory …, 2016 - meridian.allenpress.com
Context.—Gastrointestinal (GI) and pancreatobiliary tracts contain a variety of
neuroendocrine cells that constitute a diffuse endocrine system. Neuroendocrine tumors …

[HTML][HTML] Management of gastric and duodenal neuroendocrine tumors

Y Sato, S Hashimoto, K Mizuno… - World journal of …, 2016 - ncbi.nlm.nih.gov
Gastrointestinal neuroendocrine tumors (GI-NETs) are rare neoplasms, like all NETs.
However, the incidence of GI-NETS has been increasing in recent years. Gastric NETs (G …

Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma

A Berruti, S Grisanti, A Pulzer, M Claps… - The Journal of …, 2017 - academic.oup.com
Context: In 2007, a retrospective case-control study provided evidence that adjuvant
mitotane prolongs recurrence-free survival (RFS) in patients with radically resected …